Literature DB >> 26758793

Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome.

Aysegul Yildirim1, Begum Yildizhan1, Gokce Anik Ilhan1, Tanju Pekin1.   

Abstract

OBJECTIVE: To investigate the impact of urinary albumin excretion (UAE) and cystatin C on the metabolic components of polycystic ovary syndrome (PCOS).
METHODS: Seventy-five women with PCOS were divided into two groups according to metabolic syndrome as MetS + and MetS-. Clinical, metabolic and renal parameters were compared between the groups. Correlation analyses were performed between cystatin C, microalbuminuria and clinical and metabolic parameters in women with PCOS.
RESULTS: Waist/hip ratio (WHR), body mass index, LDL cholesterol, triglyceride, total cholesterol, cystatin C, UAE were significantly higher in the MetS + group compared with the MetS - one. HDL cholesterol was significantly higher in the MetS - group than the MetS + one. The UAE positively correlates with LDL cholesterol, triglyceride and total cholesterol levels. Cystatin C positively correlates with UAE, WHR, LDL cholesterol, triglyceride, total cholesterol levels.
CONCLUSIONS: Evaluating UAE and cystatin C may be important for the detection of target subjects at high risk for future metabolic syndrome and cardiovascular disease.

Entities:  

Keywords:  Cystatin C; metabolic syndrome; microalbuminuria; polycystic ovary syndrome; urinary albumin excretion

Mesh:

Substances:

Year:  2016        PMID: 26758793     DOI: 10.3109/09513590.2015.1130807

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  2 in total

1.  The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome.

Authors:  Özden Özdemir Başer; Ayşe Yeşim Göçmen; Demet Aydoğan Kırmızı
Journal:  Turk J Obstet Gynecol       Date:  2022-09-23

2.  Increased risk markers in women with polycystic ovary syndrome and gestational diabetes mellitus during mid-pregnancy.

Authors:  Liqin Zhang; Lihua Zhang; Zhangwei Wang; Lingling Zhu; Hongxing Wang; Honghui Chen; Haibo Zhang
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.